167 related articles for article (PubMed ID: 22642622)
1. NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors.
McCarthy BA; Yang L; Ding J; Ren M; King W; ElSalanty M; Zakhary I; Sharawy M; Cui H; Ding HF
BMC Cancer; 2012 May; 12():203. PubMed ID: 22642622
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.
Zhang B; Wang Z; Li T; Tsitsikov EN; Ding HF
Blood; 2007 Jul; 110(2):743-51. PubMed ID: 17405906
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.
Wang Z; Zhang B; Yang L; Ding J; Ding HF
J Biol Chem; 2008 Apr; 283(16):10698-706. PubMed ID: 18281283
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
Nadiminty N; Chun JY; Lou W; Lin X; Gao AC
Prostate; 2008 Dec; 68(16):1725-33. PubMed ID: 18781579
[TBL] [Abstract][Full Text] [Related]
5. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells.
Shen X; Zhu W; Zhang X; Xu G; Ju S
Mol Cell Biochem; 2011 Nov; 357(1-2):21-30. PubMed ID: 21607696
[TBL] [Abstract][Full Text] [Related]
6. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
[TBL] [Abstract][Full Text] [Related]
7. p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.
Vaughan CA; Singh S; Windle B; Sankala HM; Graves PR; Andrew Yeudall W; Deb SP; Deb S
Arch Biochem Biophys; 2012 Feb; 518(1):79-88. PubMed ID: 22198284
[TBL] [Abstract][Full Text] [Related]
8. Cell-autonomous role for NF-kappa B in immature bone marrow B cells.
Claudio E; Saret S; Wang H; Siebenlist U
J Immunol; 2009 Mar; 182(6):3406-13. PubMed ID: 19265118
[TBL] [Abstract][Full Text] [Related]
9. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
[TBL] [Abstract][Full Text] [Related]
10. The non-canonical NF-κB pathway promotes NPC2 expression and regulates intracellular cholesterol trafficking.
Liao Y; Wei J; Wang J; Shi X; Luo J; Song BL
Sci China Life Sci; 2018 Oct; 61(10):1222-1232. PubMed ID: 30091016
[TBL] [Abstract][Full Text] [Related]
11. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
Front Immunol; 2019; 10():997. PubMed ID: 31134075
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesis.
Tanaka S; Nakano H
J Clin Invest; 2009 Oct; 119(10):2879-81. PubMed ID: 19770519
[TBL] [Abstract][Full Text] [Related]
13. Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.
Scherger AK; Al-Maarri M; Maurer HC; Schick M; Maurer S; Öllinger R; Gonzalez-Menendez I; Martella M; Thaler M; Pechloff K; Steiger K; Sander S; Ruland J; Rad R; Quintanilla-Martinez L; Wunderlich FT; Rose-John S; Keller U
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391340
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
Scian MJ; Stagliano KE; Anderson MA; Hassan S; Bowman M; Miles MF; Deb SP; Deb S
Mol Cell Biol; 2005 Nov; 25(22):10097-110. PubMed ID: 16260623
[TBL] [Abstract][Full Text] [Related]
15. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
16. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
[TBL] [Abstract][Full Text] [Related]
17. How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?
Fathi N; Mojtahedi H; Nasiri M; Abolhassani H; Yousefpour Marzbali M; Esmaeili M; Salami F; Biglari F; Rezaei N
Expert Rev Clin Immunol; 2023 Mar; 19(3):329-339. PubMed ID: 36706462
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway.
Zhu M; Chin RK; Christiansen PA; Lo JC; Liu X; Ware C; Siebenlist U; Fu YX
J Clin Invest; 2006 Nov; 116(11):2964-71. PubMed ID: 17039258
[TBL] [Abstract][Full Text] [Related]
19. Myc suppression of Nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract][Full Text] [Related]
20. Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.
Yang L; Cui H; Wang Z; Zhang B; Ding J; Liu L; Ding HF
Am J Pathol; 2010 Jun; 176(6):2646-57. PubMed ID: 20363924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
